PharmaEngine Inc - ESG Rating & Company Profile powered by AI
If you are employed by PharmaEngine Inc and you would like to use your ESG aseessment, please get in touch. This assessment of PharmaEngine Inc is prepared by All Street Sevva using leading NLP. Alternative corporations in the scoring peer group for PharmaEngine Inc are shown below.
PharmaEngine Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.3; made up of an environmental score of 2.0, social score of 4.8 and governance score of 0.0.
2.3
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1512 | Sol Gel Technologies Ltd | 2.4 | Medium |
| 1512 | Windtree Therapeutics Inc | 2.4 | Medium |
| 1529 | PharmaEngine Inc | 2.3 | Medium |
| 1529 | ANI Pharmaceuticals Inc | 2.3 | Medium |
| 1529 | Aarti Drugs Ltd | 2.3 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does PharmaEngine Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes PharmaEngine Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes PharmaEngine Inc report the average age of the workforce?
Sign up for free to unlockDoes PharmaEngine Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes PharmaEngine Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes PharmaEngine Inc disclose cybersecurity risks?
Sign up for free to unlockDoes PharmaEngine Inc offer flexible work?
Sign up for free to unlockDoes PharmaEngine Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes PharmaEngine Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes PharmaEngine Inc conduct supply chain audits?
Sign up for free to unlockDoes PharmaEngine Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes PharmaEngine Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes PharmaEngine Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes PharmaEngine Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes PharmaEngine Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes PharmaEngine Inc disclose water use targets?
Sign up for free to unlockDoes PharmaEngine Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid PharmaEngine Inc have a product recall in the last two years?
Sign up for free to unlockDoes PharmaEngine Inc disclose incidents of discrimination?
Sign up for free to unlockDoes PharmaEngine Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas PharmaEngine Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes PharmaEngine Inc disclose parental leave metrics?
Sign up for free to unlockDoes PharmaEngine Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes PharmaEngine Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes PharmaEngine Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes PharmaEngine Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes PharmaEngine Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes PharmaEngine Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs PharmaEngine Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes PharmaEngine Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes PharmaEngine Inc disclose its waste policy?
Sign up for free to unlockDoes PharmaEngine Inc report according to TCFD requirements?
Sign up for free to unlockDoes PharmaEngine Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes PharmaEngine Inc disclose energy use targets?
Sign up for free to unlockDoes PharmaEngine Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes PharmaEngine Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for PharmaEngine Inc
These potential risks are based on the size, segment and geographies of the company.
PharmaEngine, Inc., a biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer diseases in Taiwan and Europe. It is developing ONIVYDE for patients with gemcitabine-treated metastatic pancreatic cancer; PEP06, which is in Phase I stage for the treatment of cancer; and PEP07, an oral small molecule drug, which is in preclinical development stage to regulate DNA damage response. The company was founded in 2003 and is headquartered in Taipei, Taiwan.